Hunting for Progressive NAFLD in Type 2 Diabetes: Do Not Trust Liver Enzymes!

Editorial

. 2023 Jul 1;46(7):1332-1334.

doi: 10.2337/dci23-0027.

Egeria Scoditti¹, Giulio Marchesini^{2

3}, Amalia Gastaldelli⁴

Affiliations

¹ 1Institute of Clinical Physiology, National Research Council, Lecce, Italy.
² 2Department of Medical and Surgical Sciences, Alma Mater University, Bologna, Italy.
³ 3Azienda Ospedaliera di Bologna Sant'Orsola-Malpighi, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Bologna, Italy.
⁴ 4Institute of Clinical Physiology, National Research Council, Pisa, Italy.

Editorial

Egeria Scoditti et al. Diabetes Care. 2023.

. 2023 Jul 1;46(7):1332-1334.

doi: 10.2337/dci23-0027.

Egeria Scoditti¹, Giulio Marchesini^{2

3}, Amalia Gastaldelli⁴

¹ 1Institute of Clinical Physiology, National Research Council, Lecce, Italy.
² 2Department of Medical and Surgical Sciences, Alma Mater University, Bologna, Italy.
³ 3Azienda Ospedaliera di Bologna Sant'Orsola-Malpighi, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Bologna, Italy.
⁴ 4Institute of Clinical Physiology, National Research Council, Pisa, Italy.

No abstract available

Comment on

High Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes: A Prospective Study of 330 Outpatients Undergoing Liver Biopsies for Elevated ALT, Using a Low Threshold.
Castera L, Laouenan C, Vallet-Pichard A, Vidal-Trécan T, Manchon P, Paradis V, Roulot D, Gault N, Boitard C, Terris B, Bihan H, Julla JB, Radu A, Poynard T, Brzustowsky A, Larger E, Czernichow S, Pol S, Bedossa P, Valla D, Gautier JF; QUID-NASH investigators. Castera L, et al. Diabetes Care. 2023 Jul 1;46(7):1354-1362. doi: 10.2337/dc22-2048. Diabetes Care. 2023. PMID: 37043830